Beam Therapeutics Inc

XNAS:BEAM

24.66

+0.44 (+1.82%)

7:54:00 PM EDT: $23.87 -0.79 (-3.21%)

Market Cap (Intraday)	2.56B
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$10.98 Million
Adjusted EPS	-$1.03

See more estimates

10-Day MA	N/A
50-Day MA	N/A
200-Day MA	N/A

See more pivots

Beam Therapeutics Inc Stock, XNAS:BEAM

238 Main Street, 9th floor, Cambridge, Massachusetts 02142-1016

United States of America

Phone: +1.857.327.8775

Number of Employees: 483

http://www.beamtx.com

Description

Beam Therapeutics, Inc. is a biotechnology company, which engages in the establishment of integrated platform for precision genetic medicines. Its pipeline includes BEAM-101, BEAM-302, Engineered Stem Cell Antibody Paired Evasion (ESCAPE), BEAM-301, and BEAM-201. The company was founded by David R. Liu, Feng Zhang, Alexis Komor, Nicole Gaudelli, and J. Keith Joung on January 25, 2017 and is headquartered in Cambridge, MA.